Dupilumab shows long-term effectiveness in a large cohort of treatment-refractory atopic dermatitis patients in daily practice:52-Week results from the Dutch BioDay registry
Background Real-life data on long-term effectiveness and safety of dupilumab in atopic dermatitis patients are limited. Objective To study 52-week effectiveness and safety of dupilumab in a prospective multicenter cohort of adult patients with treatment-refractory atopic dermatitis. Methods Patients treated with dupilumab and participating in the Dutch BioDay registry were included. Clinical effectiveness and safety were evaluated. Results Two hundred ten atopic dermatitis patients were included. Mean percentage change in Eczema Area and Severity Index score after 16 weeks was –70.0% (standard... Mehr ...
| Verfasser: |
Ariëns, Lieneke F.M.
van der Schaft, Jorien
Spekhorst, Lotte S.
Bakker, Daphne S.
Romeijn, Geertruida L.E.
Kouwenhoven, Tessa A.
Kamsteeg, Marijke
Voorberg, Angelique N.
Oosting, Albert J.
de Ridder, Ilona
Sloeserwij, Annemieke
Haeck, Inge
Thijs, Judith L.
Schuttelaar, Marie L.A.
de Bruin-Weller, Marjolein S. |
| Dokumenttyp: |
Artikel |
| Erscheinungsdatum: |
2021 |
| Reihe/Periodikum: |
Ariëns , L F M , van der Schaft , J , Spekhorst , L S , Bakker , D S , Romeijn , G L E , Kouwenhoven , T A , Kamsteeg , M , Voorberg , A N , Oosting , A J , de Ridder , I , Sloeserwij , A , Haeck , I , Thijs , J L , Schuttelaar , M L A & de Bruin-Weller , M S 2021 , ' Dupilumab shows long-term effectiveness in a large cohort of treatment-refractory atopic dermatitis patients in daily practice : 52-Week results from the Dutch BioDay registry ' , Journal of the American Academy of Dermatology , vol. 84 , no. 4 , pp. e279-e280 . https://doi.org/10.1016/j.jaad.2020.08.127 |
| Sprache: |
Englisch |
| Permalink: |
https://search.fid-benelux.de/Record/base-27446876 |
| Datenquelle: |
BASE;
Originalkatalog |
| Powered By: |
BASE |
| Link(s) :
|
https://hdl.handle.net/11370/ba6d1b87-1bc2-4fcc-807d-213b2b6eade3 |
